The Asia-Pacific healthcare/medical simulation market is broadly segmented into products and services. The market was valued at $312 million in 2016 and is poised to grow at a CAGR of 19.89% in the forecast period to reach $688.2 million by 2021.
The major driving force for the market are Increasing healthcare costs, Continuous innovation in technology, and increasing demand for noninvasive technologies. While major constraint for the market are Increasing cost of medical simulators, Economic slowdown, and limited funds issued by the government.
The market is divided based on Type of products(Software, Human Patient Simulators, Interventional simulation, Task traines/ Low fidelity, Anciliary products, Imaging simulation, Simulation education, Simulated Clinical Enviornments), based on geography North America, Europe, Asia-Pacific and ROW. The Americas form the largest regional market for medical simulation, Europe closely follows the America in terms of huge growth and increasing population of aged people. Asian countries such as India, China, South Korea, Malaysia, Thailand, and Singapore are likely to provide a growing market due to their increasing per capita income and emerging economy.
Prominent players in this market are Laerdal Medical (Norway), CAE Healthcare (Canada), Simulaids (U.S.), Gaumard (U.S.), Kyoto Kagako (Japan), Limbs and Things (U.K.), Education Management Solutions (U.S.), and Mentice AB (Sweden).
What makes our report unique?
1) A wide and in depth analysis of the market trends and future forecasts based on the type of products .
2) We provide longest possible market segmentation based on products and geography. We give you the competitive landscape of major players in the market and market share based on the products, and recent developments.
3) We give you the profiles of key players including company profile, Financial overview, Business strategy and developments in the market to keep pace with the changing market.